GURU.Markets stock price, segment price, and overall market index valuation
The company's share price China Pharma Holdings
China Pharma is a Chinese pharmaceutical manufacturer. Its stock price reflects the state of China's healthcare system, as well as the risks and uncertainties associated with regulation and competition in the Chinese pharmaceutical market.
Share prices of companies in the market segment - Pharma psycho
China Pharma Holdings is a Chinese company that develops, manufactures, and markets a wide range of pharmaceuticals, including psychotropic drugs. We've categorized it as "Pharma: Psycho." The chart below shows how investors view the Chinese pharmaceutical market.
Broad Market Index - GURU.Markets
China Pharma Holdings is a Chinese pharmaceutical company that produces and markets a wide range of medications. It is a component of the GURU.Markets index. The chart below shows the US market. See how this company's stock compares to the US market trend.
Change in the price of a company, segment, and market as a whole per day
CPHI - Daily change in the company's share price China Pharma Holdings
Daily fluctuations in China Pharma Holdings, Inc.'s stock reflect the volatility of China's pharmaceutical sector. This indicator demonstrates sensitivity to government procurement, pricing policies, and competition from other manufacturers.
Daily change in the price of a set of shares in a market segment - Pharma psycho
China Pharma Holdings manufactures and markets pharmaceutical products in China. The country's pharmaceutical market is vast, but subject to intense government regulation and competition. The chart below shows the average volatility in this sector, allowing one to assess the exposure of CPHI shares to general industry risks.
Daily change in the price of a broad market stock, index - GURU.Markets
China Pharma is a Chinese pharmaceutical company. Its US-traded shares are a barometer of the state of China's healthcare system and pharmaceutical market. Their dynamics add an international dimension to the overall volatility picture.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization China Pharma Holdings
For China Pharma Holdings, year-over-year performance tells the story of its performance in the Chinese pharmaceutical market. Its market capitalization change over the past 12 months reflects its success in producing and selling generics, as well as its ability to adapt to centralized procurement and other changes in Chinese government healthcare policy.
Annual dynamics of market capitalization of the market segment - Pharma psycho
China Pharma is a Chinese pharmaceutical company. Its performance is inextricably linked to the health of the Chinese economy and the country's healthcare system. This chart shows how these China-specific factors, government policy, and competition in a vast but complex market impact its performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
China Pharma Holdings, a pharmaceutical manufacturer and distributor in China, reflects the state of the country's healthcare system. Its annual market capitalization dynamics, compared to the global market, demonstrate how government reforms, pricing pressure, and generic competition are affecting traditional pharmaceutical players.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization China Pharma Holdings
China Pharma is a Chinese generic drug manufacturer. Its monthly performance reflects domestic demand for its products, as well as government drug pricing and procurement policies, which significantly impact profitability.
Monthly dynamics of market capitalization of the market segment - Pharma psycho
China Pharma Holdings manufactures and markets pharmaceuticals in China, primarily generics. The company's success depends on government pricing policies, competition, and production volumes. The chart of China's pharmaceutical sector reflects the specific regulatory and market conditions in which China Pharma operates.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
China Pharma Holdings is a Chinese pharmaceutical manufacturer. Its shares, traded in the US, reflect the state of the healthcare system and regulatory environment in China. Its share price dynamics are largely unrelated to the US market and depend on drug pricing policies and competition in China's domestic market.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization China Pharma Holdings
China Pharma, a Chinese drugmaker, primarily generics, is dependent on China's healthcare system. Its weekly stock price reflects government drug pricing policies, public procurement volumes, and the country's overall demographics.
Weekly dynamics of market capitalization of the market segment - Pharma psycho
China Pharma Holdings manufactures and sells pharmaceuticals in the Chinese market. Its performance is dependent on China's healthcare system, government policies, and competition. The chart compares this local company's performance with that of global pharmaceutical giants.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
China Pharma is a Chinese drugmaker. Its shares reflect the state of the Chinese healthcare system. This chart shows how the company's stock moves completely independently of the US stock market and its news.
Market capitalization of the company, segment and market as a whole
CPHI - Market capitalization of the company China Pharma Holdings
China Pharma Holdings' market capitalization chart reflects investors' assessment of its manufacturing capacity in China. Its dynamics reflect its business of producing generics and other pharmaceuticals for the Chinese market. Its low valuation and volatility indicate risks associated with price competition and the regulatory environment.
CPHI - Share of the company's market capitalization China Pharma Holdings within the market segment - Pharma psycho
China Pharma Holdings is a Chinese pharmaceutical manufacturer. Its sector share reflects its focus on producing generics and drugs for the domestic market. Its market capitalization reflects its weight as one of many local producers in China's vast and regulated healthcare market.
Market capitalization of the market segment - Pharma psycho
This chart shows the total market capitalization of the entire pharmaceutical sector focused on treating mental disorders. For China Pharma, which operates in this field in China, this line is a map of the nation's health. Its dynamics reflect a growing awareness of the importance of mental health in the vast Chinese market, which is driving demand for its products.
Market capitalization of all companies included in a broad market index - GURU.Markets
China Pharma Holdings manufactures and sells pharmaceutical products in China. Its market capitalization relative to the global market is an estimate of its domestic market share. It reflects the influence of one of the many drug manufacturers in the world's most populous country.
Book value capitalization of the company, segment and market as a whole
CPHI - Book value capitalization of the company China Pharma Holdings
China Pharma Holdings manufactures and sells pharmaceutical products in China. Its book value is derived from its production facilities: factories, laboratories, and drug inventories. This is the material foundation of the healthcare system. How has its value changed in the face of fierce competition? The chart below shows.
CPHI - Share of the company's book capitalization China Pharma Holdings within the market segment - Pharma psycho
China Pharma Holdings is a pharmaceutical manufacturer in China. Its business is based entirely on its production assets: factories that manufacture various medications for the domestic market. The chart shows the company's share of the physical infrastructure of the Chinese pharmaceutical industry.
Market segment balance sheet capitalization - Pharma psycho
China Pharma is a drug manufacturer. The pharmaceutical industry, as the chart shows, is capital-intensive. China Pharma is a classic player, owning factories in China that produce a wide range of drugs for the domestic market.
Book value of all companies included in the broad market index - GURU.Markets
China Pharma's assets are factories in China that produce a wide range of generic and branded medications for the Chinese market. Its book value reflects the industrial scale of this manufacturer, which supplies a vast domestic market with affordable medications. The chart shows its weighting.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - China Pharma Holdings
China Pharma Holdings is a Chinese pharmaceutical manufacturer. Its market valuation reflects its production capacity, product portfolio, and market share in China's vast but highly regulated healthcare market.
Market to book capitalization ratio in a market segment - Pharma psycho
China Pharma Holdings is a Chinese drugmaker. Its valuation on this chart will reflect not only its production capacity and product portfolio but also the risks associated with regulation, competition, and corporate governance in the Chinese pharmaceutical sector.
Market to book capitalization ratio for the market as a whole
China Pharma Holdings is a pharmaceutical manufacturer, likely focused on generics or traditional medicine. The valuation of such companies is often tied to their production capacity and market share. This metric helps understand how the market values stable but less innovative pharmaceutical businesses.
Debts of the company, segment and market as a whole
CPHI - Company debts China Pharma Holdings
China Pharma, a pharmaceutical manufacturer in China, uses debt to finance its production and distribution. This chart illustrates the financial model of a traditional pharmaceutical company operating in the large but competitive Chinese market.
Market segment debts - Pharma psycho
China Pharma Holdings manufactures and markets pharmaceuticals in China, specializing in specific therapeutic areas. This chart illustrates how the company manages its capital in the highly competitive and regulated Chinese pharmaceutical market, where pricing pressure and government procurement play a significant role.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio China Pharma Holdings
China Pharma Holdings manufactures and markets pharmaceutical products in China. Pharmaceutical production requires investment in GMP-compliant factories and R&D. This chart shows how the company manages its debt to maintain production and expand its product portfolio in the competitive Chinese market.
Market segment debt to market segment book capitalization - Pharma psycho
China Pharma Holdings is a Chinese pharmaceutical company. The pharmaceutical market in China is vast but also highly competitive. This chart shows how this small company finances its production and sales. It compares its debt load to the market capitalization of the entire pharmaceutical sector, reflecting its financial position.
Debt to book value of all companies in the market
China Pharma Holdings manufactures and markets a wide range of medications in China. The pharmaceutical business requires investment in production and compliance. How does the company manage its debt in a highly competitive and regulated market? This total debt chart helps assess its financial stability and borrowing strategy.
P/E of the company, segment and market as a whole
P/E - China Pharma Holdings
China Pharma Holdings manufactures and sells pharmaceutical products in China. This chart shows how investors value it in this vast, yet highly competitive and strictly regulated market. The valuation depends on sales volumes, regulatory approvals, and the competitive environment.
P/E of the market segment - Pharma psycho
China Pharma Holdings manufactures and markets pharmaceuticals in China. Its portfolio likely includes generics and traditional Chinese medicines. This chart reflects the average valuation for the pharmaceutical sector, which in China is characterized by a huge market, government pricing pressure, and intense competition.
P/E of the market as a whole
China Pharma Holdings is a Chinese company that develops, manufactures, and markets pharmaceuticals, primarily for the treatment of cardiovascular and cerebrovascular diseases. This chart reflects the overall sentiment in the Chinese healthcare market. It helps understand what influences the CPHI valuation more: general market trends or China-specific factors, such as government regulations.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company China Pharma Holdings
China Pharma Holdings manufactures and markets pharmaceuticals in China, specializing in treatments for various diseases. The company's success depends on the healthcare system and competition in the Chinese market. This chart shows analysts' assessments of the future of the Chinese pharmaceutical market and the company's ability to carve out a niche within it.
%20P%2FE%20China%20Pharma%20Holdings&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-China-Pharma-Holdings&v=1772650560450 "Chart of the company's future (projected) P/E China Pharma Holdings")
Future (projected) P/E of the market segment - Pharma psycho
China Pharma Holdings manufactures and markets a wide range of pharmaceutical products in China. Its success depends on regulatory approvals and competition in the vast domestic market. The chart compares the company's future profitability expectations with the sector, allowing one to assess the market's perception of its prospects.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20psycho&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-psycho&v=1772650560489 "Future (projected) P/E graph of the market segment - Pharma psycho")
Future (projected) P/E of the market as a whole
China Pharma Holdings manufactures and markets pharmaceutical products in China. The company operates in a vast, yet highly competitive and strictly regulated market. This global sentiment chart serves as a backdrop for assessing the specific risks associated with the Chinese healthcare system and pharmaceutical industry.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772650560515 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit China Pharma Holdings
China Pharma Holdings produces and sells pharmaceuticals in China, primarily generics. The company's profits depend on production volumes and state-set pricing policies. This chart shows the company's financial performance in China's vast but strictly regulated pharmaceutical market.
Profit of companies in the market segment - Pharma psycho
China Pharma Holdings produces and markets a wide range of pharmaceuticals in China, including both generic and branded medications. Its success depends on China's healthcare system. This chart shows the overall profitability of the psychopharmacology and generics sector, which in China is heavily dependent on government procurement and pricing policies.
Overall market profit
China Pharma Holdings manufactures and markets pharmaceutical products in China. Demand for medications, particularly those treating common diseases, is stable and inelastic. This makes the company's business more defensive and less dependent on economic cycles, as can be seen in this chart, than many other industries.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company China Pharma Holdings
China Pharma Holdings produces and markets a wide range of pharmaceuticals in China. The company's future profitability depends on sales volumes, government pricing policies, and competition in China's vast but complex pharmaceutical market. This chart shows analysts' assessments of its position and prospects.
%20profit%20of%20the%20company%20China%20Pharma%20Holdings&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-China-Pharma-Holdings&v=1772650560550 "Graph of future (projected) profit of the company China Pharma Holdings")
Future (predicted) profit of companies in the market segment - Pharma psycho
China Pharma Holdings manufactures and markets a wide range of pharmaceuticals in China, including both prescription and over-the-counter medications. The company's success depends on the country's healthcare system and regulatory environment. This chart shows profitability expectations for the psychopharmaceutical sector, providing context for assessing China Pharma's position.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20psycho&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-psycho&v=1772650560551 "Graph of future (predicted) profits of companies in a market segment - Pharma psycho")
Future (predicted) profit of the market as a whole
China Pharma Holdings manufactures and markets pharmaceuticals in China. Demand for its products, primarily generics, is stable but dependent on government healthcare policy. This economic expectations chart is indirectly important because it reflects the overall state of the economy, which impacts healthcare budgets.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772650560565 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - China Pharma Holdings
China Pharma Holdings manufactures and sells pharmaceutical products in China. Revenue is driven by domestic sales of its products. This chart shows how investors view its product portfolio and its position in China's complex and regulated healthcare system.
P/S market segment - Pharma psycho
China Pharma Holdings produces and markets a wide range of pharmaceuticals in the Chinese market, including both generic and branded medications. The company meets the basic needs of China's vast healthcare system. This chart shows the average revenue estimate for the sector, allowing one to assess the company's position in the domestic pharmaceutical market.
P/S of the market as a whole
China Pharma Holdings manufactures and sells pharmaceutical products in China. This chart, which displays average market revenue estimates, allows investors to compare how this traditional drugmaker, operating in the vast but highly competitive and regulated Chinese market, compares to other companies.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company China Pharma Holdings
China Pharma Holdings manufactures and markets pharmaceutical products in China, including generic and branded drugs. The company's future revenue depends on demand for its medications and regulatory policies in China's healthcare system. This chart shows how investors assess its ability to compete in China's large but complex pharmaceutical market.
%20P%2FS%20China%20Pharma%20Holdings&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-China-Pharma-Holdings&v=1772650560655 "The graph of the company's future (projected) P/S China Pharma Holdings")
Future (projected) P/S of the market segment - Pharma psycho
China Pharma Holdings manufactures and markets pharmaceuticals in China, specializing in various therapeutic areas. This chart compares the company's estimated future sales with expectations for the pharmaceutical sector. It shows how investors view its product portfolio, production capacity, and ability to compete in the vast, yet regulated, Chinese pharmaceutical market.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20psycho&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-psycho&v=1772650560660 "Future (projected) P/S market segment graph - Pharma psycho")
Future (projected) P/S of the market as a whole
China Pharma Holdings manufactures and markets pharmaceuticals in China, focusing on generics. The company's success depends on government pricing policies and domestic competition. This graph of investor expectations reflects their view of China's vast, yet complex and regulated pharmaceutical market.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772650560679 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales China Pharma Holdings
The chart illustrates China Pharma Holdings' revenue from pharmaceutical production and sales in China. Revenue dynamics are directly dependent on domestic drug sales volumes, competition, and Chinese government healthcare policy.
Sales of companies in the market segment - Pharma psycho
China Pharma Holdings manufactures and markets pharmaceuticals in China. Its sales breakdown shows which therapeutic areas (e.g., cardiovascular, neurological) contribute the most to revenue. This reflects its product portfolio and focus on specific segments of the Chinese healthcare market.
Overall market sales
China Pharma Holdings manufactures and markets pharmaceutical products in China. The company operates in the healthcare sector, one of the most stable and fastest-growing in the country. This chart of overall economic activity helps understand how the growth of China's healthcare sector, driven by demographics and rising incomes, relates to overall economic trends.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company China Pharma Holdings
China Pharma Holdings produces and sells a wide range of pharmaceuticals in the Chinese market. Revenue growth depends on demand for its products, competition, and government healthcare policies in China. This chart reflects analyst expectations for the state of the Chinese pharmaceutical market and the company's ability to maintain or increase its market share.
%20sales%20of%20the%20company%20China%20Pharma%20Holdings&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-China-Pharma-Holdings&v=1772650560691 "Schedule of future (projected) sales of the company China Pharma Holdings")
Future (projected) sales of companies in the market segment - Pharma psycho
China Pharma Holdings produces and markets a wide range of pharmaceuticals in China. This chart shows the forecast for the entire pharmaceutical market. How do the aging population and government healthcare reforms in China influence analysts' expectations for drug demand growth? This sets the overall tone for the company.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20psycho&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-psycho&v=1772650560704 "Schedule of future (projected) sales of companies in the market segment - Pharma psycho")
Future (projected) sales of the market as a whole
China Pharma Holdings manufactures and markets pharmaceutical products in China. Demand for medications, particularly essential ones, is stable and inelastic. However, this general economic pattern impacts government healthcare budgets and consumers' ability to afford more expensive or over-the-counter medications, which could impact the company's growth.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772650560723 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality China Pharma Holdings
China Pharma Holdings manufactures and markets pharmaceuticals in China, specializing in drugs for the central nervous, cardiovascular, and gastrointestinal systems. This chart shows how the company operates in the vast but regulated Chinese pharmaceutical market. Its profitability depends on production volumes, pricing policies, and regulatory approvals.
Market segment marginality - Pharma psycho
China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products in China. The company's profitability depends on sales volume, state-set drug prices, and production efficiency. This chart shows how the company operates in China's vast but highly regulated pharmaceutical market.
Market marginality as a whole
China Pharma Holdings manufactures and markets pharmaceutical products in China. Its success depends on demand for medications in the vast domestic market and government healthcare policies. This chart, while global, reflects general economic trends that impact consumer spending and healthcare budgets.
Employees in the company, segment and market as a whole
Number of employees in the company China Pharma Holdings
China Pharma Holdings manufactures and markets generic drugs and other pharmaceutical products in China. The number of employees at its factories is directly related to production volumes. This chart shows how the company manages its production capacity to meet demand for its products within the Chinese healthcare system.
Share of the company's employees China Pharma Holdings within the market segment - Pharma psycho
China Pharma Holdings manufactures and markets pharmaceuticals in China. Managing production lines that comply with GMP standards requires a large staff of pharmacists, chemists, and laborers. This chart shows the company's labor market share, which directly reflects its production capacity and the scale of its operations in the Chinese pharmaceutical market.
Number of employees in the market segment - Pharma psycho
China Pharma Holdings manufactures and markets a wide range of pharmaceuticals in China, including generic and branded medications. This chart shows its operations in the psychopharmaceuticals sector and other areas. China's vast and growing healthcare market ensures stable demand for its products.
Number of employees in the market as a whole
China Pharma Holdings manufactures and sells pharmaceuticals in China. Its business is tied to the country's stable healthcare sector. This chart shows the US market, but China Pharma is a good example of how the pharmaceutical industry in any country is a large and stable employer, providing medicines regardless of economic cycles.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company China Pharma Holdings (CPHI)
China Pharma Holdings is a Chinese pharmaceutical manufacturer, including both generic and branded drugs. It is a traditional, capital-intensive manufacturing company. This chart shows market capitalization per employee. It reflects the value of their factories and product portfolio more than their breakthrough R&D.
%20of%20the%20company%20China%20Pharma%20Holdings%20(CPHI)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-China-Pharma-Holdings-CPHI&v=1772650561057 "Chart of market capitalization per employee (in thousands of dollars) of the company China Pharma Holdings (CPHI)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma psycho
China Pharma Holdings (CPHI) manufactures and markets a wide range of pharmaceuticals in China. For a generic pharmaceutical company, this metric may reflect the scale of production and distribution efficiency. Deviations from the average may be due to successful production of in-demand drugs or the presence of a strong distribution network across the country.
%20by%20market%20segment%20-%20Pharma%20psycho&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-psycho&v=1772650561097 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma psycho")
Market capitalization per employee (in thousands of dollars) for the overall market
China Pharma Holdings manufactures and sells pharmaceutical products in China. For a traditional pharmaceutical company, this metric reflects the balance between production capacity and its drug portfolio. The market evaluates the company's ability to efficiently produce and sell drugs in the large and competitive Chinese market.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772650561100 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company China Pharma Holdings (CPHI)
China Pharma Holdings is a Chinese pharmaceutical manufacturer, primarily of generic drugs. It's a classic pharmaceutical manufacturing business. This chart shows how efficiently the company's factories operate. Profit per employee is a direct result of the company's production line efficiency and its ability to compete in the generics market.
%20Chart%20China%20Pharma%20Holdings%20(CPHI)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-China-Pharma-Holdings-CPHI&v=1772650561139 "Company Profit Per Employee (in thousands of dollars) Chart China Pharma Holdings (CPHI)")
Profit per employee (in thousands of dollars) in the market segment - Pharma psycho
China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products in China. For a pharmaceutical manufacturer, productivity per employee is an indicator of operational excellence and demand for its products. This chart allows you to evaluate the company's profitability compared to other players in the vast Chinese market.
%20in%20the%20market%20segment%20-%20Pharma%20psycho&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-psycho&v=1772650561191 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma psycho")
Profit per employee (in thousands of dollars) for the market as a whole
China Pharma Holdings is a Chinese pharmaceutical manufacturer. Unlike its R&D biotech operations, it is primarily a manufacturing company, producing generics and traditional medications. This chart shows how profitable traditional pharmaceutical manufacturing, which requires factories and workers, is per employee.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772650561220 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee China Pharma Holdings (CPHI)
China Pharma Holdings manufactures and markets pharmaceutical products in China. This chart reflects the company's operational performance in its vast domestic market. The increase in revenue per employee can be attributed to automation, expansion of the product portfolio, and increased sales volumes.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-China-Pharma-Holdings-CPHI&v=1772650561238 "Sales chart per company employee China Pharma Holdings (CPHI)")
Sales per employee in the market segment - Pharma psycho
China Pharma Holdings (CPHI) is a Chinese manufacturer of generics (drug analogs) and other pharmaceuticals for the Chinese market. It's a classic pharmaceutical company. This chart shows the average output in the sector. For CPHI, this is an indicator of how productive their factories and sales team are compared to other generic manufacturers.
Sales per employee for the market as a whole
China Pharma Holdings manufactures and sells pharmaceuticals (primarily generics) in China. It's a classic manufacturing business. This indicator shows how efficient their factories and assembly lines are in producing and distributing drugs in the competitive Chinese market.
Short shares by company, segment and market as a whole
Shares shorted by company China Pharma Holdings (CPHI)
China Pharma (CPHI) is a Chinese generic drug manufacturer. This chart shows the number of short positions. Short positions may be related to fierce price competition in the generic drug market in China, regulatory pressure, or the company's overall lack of transparency.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-China-Pharma-Holdings-CPHI&v=1772650561357 "Short Shares Chart for the Company China Pharma Holdings (CPHI)")
Shares shorted by market segment - Pharma psycho
China Pharma Holdings (CPHI) is a Chinese pharmaceutical manufacturer specializing in generic and over-the-counter drugs. This chart shows the total short position in the generics sector. It reflects investor concerns about government pricing pressure and intense competition in China.
Shares shorted by the overall market
China Pharma is a Chinese generics manufacturer. This chart shows the overall market pessimism. For investors, this poses a dual risk: a slowing Chinese economy and, more importantly, the government's VBP policy (generic price pressure), which is eroding the profitability of all pharmaceutical manufacturers in the country.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator China Pharma Holdings (CPHI)
China Pharma is a Chinese manufacturer of generic drugs and pharmaceuticals. Their business depends on government procurement and the regulatory environment in China. This oscillator measures the "temperature" of these risks. It "warms up" on positive earnings reports and "cools down" on news about changes in drug pricing policies.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-China-Pharma-Holdings-CPHI&v=1772650561508 "RSI 14 indicator chart for the company's stock China Pharma Holdings (CPHI)")
RSI 14 Market Segment - Pharma psycho
China Pharma (CPHI) is a Chinese manufacturer of generics and pharmaceuticals for the Chinese market. This chart tracks overall sentiment in the pharmaceutical sector. It helps investors distinguish between CPHI's specific regulatory and economic risks in China and the overall overheating or oversold situation in the global pharmaceutical sector.
RSI 14 for the overall market
China Pharma (CPHI), a Chinese pharmaceutical company, sees a dual risk in this chart: biotech and geopolitics. In times of euphoria, investors are willing to invest in both risky R&D and China. In moments of panic, capital flees both biotech and Chinese assets, creating a perfect storm for the company.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast CPHI (China Pharma Holdings)
China Pharma Holdings is a Chinese manufacturer producing a portfolio of generic and branded drugs for the Chinese market. This chart shows the speculative average price target from analysts, reflecting their view on sales volumes and the high risks associated with pricing reforms in China.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-CPHI-China-Pharma-Holdings&v=1772650561640 "A chart showing analyst consensus forecasts for the expected stock price. CPHI (China Pharma Holdings)")
The difference between the consensus estimate and the actual stock price CPHI (China Pharma Holdings)
China Pharma is a Chinese manufacturer specializing in generics (analogs) and branded drugs for the Chinese market. This chart measures the gap between the current price and the consensus target price. It shows whether experts believe they can compete in the generics market under China's VBP (public procurement) policy.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-CPHI-China-Pharma-Holdings&v=1772650561656 "A chart showing the difference between the consensus forecast and the actual stock price. CPHI (China Pharma Holdings)")
Analyst consensus forecast for stock prices by market segment - Pharma psycho
China Pharma (CPHI) is a Chinese manufacturer of generics (copy drugs) and nutraceuticals focused on the domestic market. This chart shows general expectations for the pharmaceutical sector. It reflects whether experts believe the Chinese generics market is stable or whether they expect price pressure from the government.
Analysts' consensus forecast for the overall market share price
China Pharma Holdings is a Chinese pharmaceutical manufacturer, primarily of generics (copies) for the treatment of cardiovascular and mental health conditions. This chart shows the overall sentiment of the *global* market. For CPHI, which operates in the "defensive" sector but in a jurisdiction with geopolitical risks (China), general optimism is important, but investors weigh it against the specific risks of the region.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index China Pharma Holdings
China Pharma is a veteran of the Chinese pharmaceutical industry. They produce generics (analogs) and branded medications for the domestic Chinese market, specializing in psychotropic and cardiovascular medications. This chart is a barometer of the Chinese pharmaceutical industry. It reflects their low-margin sales and the critically high risks associated with price wars (VBP) and Beijing's regulations.
AKIMA Market Segment Index - Pharma psycho
China Pharma Holdings (CPHI) is a Chinese pharmaceutical manufacturer. The company develops and markets a wide range of generic and branded medications (from cardio to CNS) for the domestic Chinese market, operating through its own distribution network. This chart shows the average index for the segment. It helps investors assess how CPHI performs relative to the market average.
The AKIM Index for the overall market
China Pharma Holdings is a Chinese pharmaceutical company that develops and markets generic and biochemical drugs. This chart, showing the average (global/US) market value, serves as a benchmark. It helps assess how CPHI, a player in China's domestic pharmaceutical market, compares to overall macroeconomic trends.
